CAR T-Cell Therapy KTE-C19 Emerges Successful in Aggressive B-Cell Lymphoma Tweet this page Chimeric antigen receptor (CAR) T-cell therapy proceeds to have extraordinaire showings in patients with aggressive hematologic malignancies and no other good treatment options. Interim results of the pivotal phase II ZUMA-1 trial, the very first multicenter trial of the experimental CAR T-cell […]